Illinois Governor Pritzker Signs HB 3639 into Law, Capping Epinephrine Auto-Injector Costs at $60
Landmark Legislation Ensures Accessible and Affordable Epinephrine for All Illinois Residents
August 7, 2023 (McLean, VA) – FARE (Food Allergy Research & Education), the nation’s leading non-profit organization engaged in food allergy advocacy, and the largest private funder of food allergy research, is thrilled to announce a groundbreaking victory for individuals and families managing severe food allergies in the state of Illinois. On Friday, August 4, Illinois Governor J.B. Pritzker signed into law House Bill 3639 (HB 3639), which sets a crucial precedent by capping the cost of epinephrine auto-injectors in the state at $60.
Epinephrine auto-injectors are life-saving devices that are essential for individuals with severe food allergies. Yet, the prohibitive cost has been a significant barrier, leaving many vulnerable individuals without access to this critical medication. With the signing of HB 3639, Illinois joins the fight for affordable access to epinephrine, ensuring that no one must choose between their health and financial stability.
“We commend Governor Pritzker for his leadership and commitment to the health and well-being of Illinois residents,” said Jason Linde, Senior Vice President, Advocacy, FARE. “On behalf of the more than 1.2 million state residents with potentially life-threatening food allergies, FARE is grateful for all of the Illinois grassroots advocates, Rep. Joyce Mason, Senator Mike Halpin, and the food allergy champions in the Illinois State House and Senate who made it possible for all families to afford the medicine they need.”
FARE has been a staunch advocate for legislative measures that make epinephrine more accessible and affordable. This law in Illinois is a significant milestone in these ongoing efforts, setting the stage for even more states to follow suit and prioritize the health and safety of their residents. FARE remains dedicated to advancing policies that protect and empower individuals with food allergies, and encourages other states to take decisive action to address the critical issue of epinephrine affordability.
For more information about FARE’s advocacy efforts and to join the food allergy movement, please visit here.
Media Contact:
About FARE
FARE (Food Allergy Research & Education) is the nation’s leading non-profit engaged in food allergy advocacy and the largest food allergy charity supporting research. FARE’s innovative education, advocacy and research initiatives transform the future of food allergy through new and improved treatments and prevention strategies, effective policies and legislation, and novel approaches to managing the disease. To learn more, visit: foodallergy.org.